Evidence map›Paper›PMID 36009902›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Treatment Heterogeneity in

Aisling R Caffrey, Haley J Appaneal, J Xin Liao, Emily C Piehl, Vrishali Lopes, Laura A Puzniak

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Structural and Computational Analysis ofbioRxiv : the preprint server for biology · 2025
    Article
  3. Review
  4. Article
  5. Antimicrobial resistance ofFrontiers in microbiology · 2024
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Aisling R CaffreyInfectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, RI 02908, USA.ORCID 0000-0002-4180-027X
Haley J AppanealInfectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, RI 02908, USA.ORCID 0000-0002-2407-7032
J Xin LiaoInfectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, RI 02908, USA.
Emily C PiehlInfectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, RI 02908, USA.
Vrishali LopesInfectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, RI 02908, USA.
Laura A PuzniakMerck & Co., Inc., Rahway, NJ 07065, USA.

Funding

MSD (United Kingdom) 6844
6 · The paper itself

Abstract

We have previously identified substantial antibiotic treatment heterogeneity, even among organism-specific and site-specific infections with treatment guidelines. Therefore, we sought to quantify the extent of treatment heterogeneity among patients hospitalized with

Indexed as

antibioticsanti-pseudomonal antibioticspneumoniaPseudomonas aeruginosatreatment heterogeneity

Identifiers

PMID36009902
PMCPMC9405358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.